- Clinical Trials
- January 2024
- 60 Pages
Global
From €1208EUR$1,250USD£1,039GBP
Selective COX 2 Inhibitors are a type of analgesic drug used to treat pain and inflammation. They are a type of non-steroidal anti-inflammatory drug (NSAID) that selectively target the COX-2 enzyme, which is responsible for inflammation and pain. This type of drug is often used to treat conditions such as arthritis, menstrual cramps, and other chronic pain conditions. Selective COX 2 Inhibitors are generally considered to be safer than traditional NSAIDs, as they have fewer side effects and are less likely to cause gastrointestinal problems.
Some of the companies in the Selective COX 2 Inhibitors Drug market include Pfizer, Merck, Novartis, and AstraZeneca. These companies produce a variety of drugs in this category, including Celebrex, Vioxx, and Bextra. Show Less Read more